Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-13 Purchase | 2026-10-13 6:12 pm | Retension Pharmaceuticals Inc. | RTSN | Keller Eric L. CHIEF EXECUTIVE OFFICER | 20,800 | $12 | $249,600 | 719,581 (Direct) | View |
| 2026-10-13 Purchase | 2026-10-13 6:10 pm | Retension Pharmaceuticals Inc. | RTSN | BERGER FRANKLIN M Director | 10,000 | $12 | $120,000 | 22,517 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-13 Option Award | 2026-10-13 6:12 pm | N/A 2036-10-13 | Retension Pharmaceuticals Inc. | RTSN | Keller Eric L. CHIEF EXECUTIVE OFFICER | 255,174 | $0 | 719,581 (Direct) | View |
| 2026-10-13 Conversion | 2026-10-13 6:12 pm | N/A N/A | Retension Pharmaceuticals Inc. | RTSN | Keller Eric L. CHIEF EXECUTIVE OFFICER | 41,030 | $0 | 719,581 (Direct) | View |
| 2026-10-13 Conversion | 2026-10-13 6:12 pm | N/A N/A | Retension Pharmaceuticals Inc. | RTSN | Sweetnam Paul CHIEF SCIENTIFIC OFFICER | 6,666 | $0 | 409,243 (Direct) | View |
| 2026-10-13 Conversion | 2026-10-13 6:11 pm | N/A N/A | Retension Pharmaceuticals Inc. | RTSN | Olds Donald Director | 5,637 | $0 | 5,637 (Direct) | View |
| 2026-10-13 Option Award | 2026-10-13 6:11 pm | N/A 2036-10-13 | Retension Pharmaceuticals Inc. | RTSN | Cheruvu Pavan Director | 5,636 | $0 | 5,636 (Direct) | View |
| 2026-10-13 Conversion | 2026-10-13 6:11 pm | N/A N/A | Retension Pharmaceuticals Inc. | RTSN | Bisson Sabine CHIEF OPERATING OFFICER | 4,115 | $0 | 4,115 (Direct) | View |
| 2026-10-13 Conversion | 2026-10-13 6:10 pm | N/A N/A | Retension Pharmaceuticals Inc. | RTSN | BERGER FRANKLIN M Director | 12,517 | $0 | 22,517 (Direct) | View |
| 2026-10-13 Conversion | 2026-10-13 6:10 pm | N/A N/A | Retension Pharmaceuticals Inc. | RTSN | BERENDT MICHAEL J Director | 6,666 | $0 | 6,666 (Direct) | View |
| 2026-10-08 Option Award | 2026-10-08 9:39 pm | N/A 2036-10-08 | Retension Pharmaceuticals Inc. | RTSN | BERENDT MICHAEL J Director | 5,636 | $0 | 5,636 (Direct) | View |
| 2026-10-08 Option Award | 2026-10-08 9:39 pm | N/A 2036-10-08 | Retension Pharmaceuticals Inc. | RTSN | Olds Donald Director | 5,636 | $0 | 5,636 (Direct) | View |
| 2026-10-08 Option Award | 2026-10-08 9:38 pm | N/A 2036-10-08 | Retension Pharmaceuticals Inc. | RTSN | BERGER FRANKLIN M Director | 5,636 | $0 | 5,636 (Direct) | View |
Ownership | 2026-10-08 6:38 pm | N/A 2036-04-30 | Retension Pharmaceuticals Inc. | RTSN | Schwartz Alexander Duke Chief Financial Officer | 0 | $0 | 64,413 (Direct) | View |
Ownership | 2026-10-08 6:37 pm | N/A N/A | Retension Pharmaceuticals Inc. | RTSN | Sweetnam Paul Chief Scientific Officer | 0 | $0 | 618,584 (Direct) | View |
Ownership | 2026-10-08 6:37 pm | N/A 2036-04-30 | Retension Pharmaceuticals Inc. | RTSN | Schecter Alison D. Chief Medical Officer | 0 | $0 | 152,980 (Direct) | View |
Ownership | 2026-10-08 6:36 pm | N/A 2034-09-22 | Retension Pharmaceuticals Inc. | RTSN | Olds Donald Director | 0 | $0 | 70,050 (Direct) | View |
Ownership | 2026-10-08 6:36 pm | N/A N/A | Retension Pharmaceuticals Inc. | RTSN | Keller Eric L. Chief Executive Officer | 0 | $0 | 685,155 (Direct) | View |
Ownership | 2026-10-08 6:36 pm | N/A 2034-09-22 | Retension Pharmaceuticals Inc. | RTSN | Bisson Sabine Chief Operating Officer | 0 | $0 | 52,425 (Direct) | View |
Ownership | 2026-10-08 6:35 pm | N/A 2036-04-30 | Retension Pharmaceuticals Inc. | RTSN | BERGER FRANKLIN M Director | 0 | $0 | 22,179 (Direct) | View |
Ownership | 2026-10-08 6:35 pm | N/A 2034-09-22 | Retension Pharmaceuticals Inc. | RTSN | BERENDT MICHAEL J Director | 0 | $0 | 71,079 (Direct) | View |